NCT07751419

Brief Summary

Periodontal disease causes inflammation and damage to the tissues that support the teeth. This study looks at whether stress inside gum cells contributes to this damage. Cells have a stress response system that helps them deal with damaged or misfolded proteins. This study measured several markers of this cell stress response (called GRP78, PERK, IRE1, ATF6, MANF, CRELD2) along with a marker of inflammation (TNF-α). These were measured in fluid collected from around the teeth and in small samples of gum tissue. Researchers compared 72 healthy adults who did not smoke, divided into three equal groups: people with healthy gums, people with mild gum inflammation (gingivitis), and people with a more advanced form of gum disease (periodontitis). The results showed that markers of cell stress were higher in people with periodontitis compared to the other two groups, both in the fluid around the teeth and in the gum tissue itself. This suggests that cell stress inside gum tissue may play a role in the inflammation and tissue breakdown seen in periodontitis. These findings may help researchers better understand what drives gum disease and could guide future work on new ways to detect or treat it.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2026

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 3, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 7, 2026

Completed
Last Updated

August 7, 2026

Status Verified

August 1, 2026

Enrollment Period

5 months

First QC Date

August 3, 2026

Last Update Submit

August 3, 2026

Conditions

Keywords

endoplasmic reticulumER stressUnfolded Protein ResponsePeriodontal InflammationGingival Crevicular FluidGingiva

Outcome Measures

Primary Outcomes (1)

  • GCF, Gingival tissue levels of GRP78, PERK, IRE1, ATF6, MANF, CRELD2, and TNF-α.

    Gene expression (RT-PCR, relative fold change via 2\^-ΔΔCT method) levels of GRP78, PERK, IRE1, ATF6, MANF, CRELD2, and TNF-α were measured in gingival tissue samples of participants. Protein levels of GRP78, PERK, IRE1, ATF6, MANF, CRELD2, and TNF-α in GCF and gingival tissue samples were measured by ELISA in study participants.

    From September 2025 to February 2026

Study Arms (3)

periodontally healthy

periodontally healthy participants

gingivitis

patients with gingivitis

periodontitis

patients with periodontitis

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 18 to 65 years attending the periodontology clinic were enrolled and classified into three groups based on clinical periodontal parameters according to the 2017 World Workshop classification: periodontal health, gingivitis, and periodontitis (Stage III). Exclusion criteria included any systemic disease, regular medication use, smoking, pregnancy or lactation, periodontal treatment within the past 6 months, antibiotic use within the past 6 months, and presence of prosthetic restorations on the teeth to be sampled. A total of 72 participants (24 per group; 36 male, 36 female) were included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kubra Aral

Malatya, 44100, Turkey (Türkiye)

Location

Related Publications (4)

  • Teles R, Sakellari D, Teles F, Konstantinidis A, Kent R, Socransky S, Haffajee A. Relationships among gingival crevicular fluid biomarkers, clinical parameters of periodontal disease, and the subgingival microbiota. J Periodontol. 2010 Jan;81(1):89-98. doi: 10.1902/jop.2009.090397.

    PMID: 20059421BACKGROUND
  • Jiang M, Li Z, Zhu G. The role of endoplasmic reticulum stress in the pathophysiology of periodontal disease. J Periodontal Res. 2022 Oct;57(5):915-932. doi: 10.1111/jre.13031. Epub 2022 Jul 12.

    PMID: 35818935BACKGROUND
  • Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011 Nov 25;334(6059):1081-6. doi: 10.1126/science.1209038.

    PMID: 22116877BACKGROUND
  • Aral K, Aral CA, Kapila Y. The role of caspase-8, caspase-9, and apoptosis inducing factor in periodontal disease. J Periodontol. 2019 Mar;90(3):288-294. doi: 10.1002/JPER.17-0716. Epub 2018 Oct 26.

    PMID: 30311940BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Residual gingival crevicular fluid (GCF) samples and complementary DNA (cDNA) samples synthesized from extracted RNA will be retained as backup specimens. Retained GCF samples will be used only if repeat ELISA analysis is required due to technical issues, such as assay failure, insufficient sample volume, or inconclusive results. Retained cDNA samples will be used only if repeat RT-qPCR analysis is required for the same reasons. No genomic DNA extraction will be performed on any retained specimen, and retained specimens will not be used to extract or analyze genomic DNA. All samples will be stored at -80°C and will be used exclusively for quality control and re-analysis purposes related to this study.

MeSH Terms

Conditions

PeriodontitisGingivitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesInfectionsGingival Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 3, 2026

First Posted

August 7, 2026

Study Start

September 15, 2025

Primary Completion

February 15, 2026

Study Completion

February 15, 2026

Last Updated

August 7, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be shared, including participant age, sex, and clinical periodontal parameters (plaque index, gingival index, probing depth, clinical attachment level, bleeding on probing). Participants will be identified only by coded/numbered case report forms; no names, gender identity beyond biological sex, or other identifying information will be shared.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 6 months and ending 24 months following article publication
Access Criteria
Data will be made available to researchers who provide a methodologically sound proposal, subject to approval by the corresponding author, for the purpose of achieving the aims outlined in the approved proposal.

Locations